Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

astrazeneca_sign_sky

AstraZeneca jettisons schizophrenia drug for $538 million

May 8, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Luye Pharma, Seroquel, pharma, schizophrenia

AstraZeneca has confirmed it has signed a deal to jettison its schizophrenia drug Seroquel and its extended release version Seroquel …
News
takeda_global_hq

It’s official: Takeda to buy Shire for £46 billion

May 8, 2018 Manufacturing and Production, Sales and Marketing Shire, Takeda, acquisition, pharma

After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …
News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Los Angeles becomes latest US city to sue pharma over opioid crisis

May 4, 2018 Medical Communications, Sales and Marketing Los Angeles, opioid crisis, pharma

The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing …
News
baby-784607_960_720

Mallinckrodt gets two thumbs down from FDA for jaundice drug

May 4, 2018 Medical Communications, Sales and Marketing InfaCare, Mallinckrodt, biotech, drugs, pharma, pharmaceutical

Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …
News
webinar

Free webinar – Rational EU risk management for oncology medicines

May 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA Group, biotech, drugs, pharma, pharmaceutical

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …
News
bms

BMS looks to leverage real-world data, with Flatiron collab

May 3, 2018 Medical Communications, Sales and Marketing Bristol-Myers Squibb, Flatiron health, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be …
News
sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …
Feature

Sandoz US woes continue with biosimilar rejection

May 3, 2018 Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …
News
20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018 Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …
News
novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018 Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …
News
praluentalirocumab_1211441

Sanofi/Regeneron forced to slash price in wake of slow sales

May 1, 2018 Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …
News
jon_neal-1_0

Takeda announces new UK MD, ahead of Shire transformation

May 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
Appointment
credit_rich_s

United Therapeutics to acquire SteadyMed for $216 million

May 1, 2018 Manufacturing and Production, Sales and Marketing SteadyMed, UnitedTherapeutics, acquisition, pharma

United Therapeutics is set to acquire speciality pharma firm SteadyMed after it emerged that the pair had signed a definitive …
News
medopad

Connecting patients to doctors

April 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026